Physician

Matthew Kenneth Chatfield, M.D.

According to 2025 Medicare claims, Matthew Chatfield, M.D. (NPI: 1720379829) practices family practice in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Walker, GA. This provider's primary affiliated billing organization is ERLANGER HEALTH (NPI: 1871295709; TIN: 883616696) and primary practice location at 30736-3179. Chatfield is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Chatfield's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 186 traditional Medicare patients, billed 8,826 HCPCS/CPT codes, and received $73,920 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 4,213 prescription claims across 303 beneficiaries totaling $494,012 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 38 claims. Open Payments data shows 41 records totaling $882. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $12,547 and ending at $73,920. Concurrently, Part D prescription costs have risen steadily, from $37,331 to $494,012. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $35,917 to $6,573.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	85	386	$12,547
2016	298	1,930	$65,172
2017	383	7,037	$95,261
2018	339	8,655	$79,503
2019	356	3,845	$87,117
2020	262	3,707	$71,628
2021	233	6,497	$79,356
2022	186	6,904	$58,054
2023	149	7,088	$52,441
2024	186	8,826	$73,920

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	79	396	$37,331
2016	201	1,575	$83,090
2017	301	3,656	$240,168
2018	327	4,431	$302,849
2019	473	2,978	$227,755
2020	396	4,464	$365,369
2021	424	4,729	$462,090
2022	486	4,848	$590,353
2023	405	4,608	$653,533
2024	303	4,213	$494,012

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	93	$1,648
2018	13	65	$1,566
2019	12	103	$3,113
2020	14	101	$1,717
2021	N/R	64	$1,451
2022	N/R	32	$642
2023	N/R	N/R	N/R
2024	N/R	38	$1,448

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	71	71	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	132	262	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	62	87	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	86	163	$11
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	37	254	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	44	2,186	$82,006
Eliquis	Apixaban	47	2,564	$45,476
Trulicity	Dulaglutide	17	1,322	$40,629
Ozempic	Semaglutide	21	954	$30,708
Farxiga	Dapagliflozin Propanediol	18	1,260	$23,979

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	13	$806
E1392	Portable oxygen concentrator, rental	Y	N/R	13	$420
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	12	$222

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	41	$882	Dexcom, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew Kenneth Chatfield, M.D.?

Tedicare shows public-source Medicare data for Matthew Kenneth Chatfield, M.D. (NPI 1720379829), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Kenneth Chatfield, M.D. have ACO affiliation data?

Matthew Kenneth Chatfield, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Matthew Kenneth Chatfield, M.D.?

Matthew Kenneth Chatfield, M.D. is linked to ERLANGER HEALTH (billing NPI 1871295709) in the available physician profile data.

Does Matthew Kenneth Chatfield, M.D. have Open Payments data?

Matthew Kenneth Chatfield, M.D. has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.